Biophytis Announces Plan to Publicly File Later Today Registration Statement for Proposed Initial Public Offering in the United States - Seite 2

No communication or information relating to the ADS Offering by Biophytis may be transmitted to the public in a country where there is a registration obligation or where an approval is required. The issuance or the subscription of the securities of the Company may be subject to legal and regulatory restrictions in certain jurisdictions; none of Biophytis and the bank involved in the ADS Offering assumes any liability in connection with the breach by any person of such restrictions.

This press release is an advertisement and not a prospectus within the meaning of Directive 2003/71/EC of the European Parliament and the Council of 4 November 2003, as amended or superseded including by Directive 2010/73/EU and as implemented in each member state of the European Economic Area, and of EU Regulation 2017/1129 as supplemented by EU Regulation 2019/980 (the “Prospectus Regulations”).

This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to any securities of Biophytis in any country. This press release is not an offer to the public, an offer to subscribe or designed to solicit interest for purposes of an offer to the public in any jurisdiction, including France.

This press release was written in French and English. If there is a difference between the texts, the French version will prevail.

Biophytis Investor Relations Contact	Media Contact
Evelyne Nguyen – CFO	LifeSci Advisors
[e-mail]	Sophie Beaumont
	[e-mail]
	Mobile: [phone]
Investor Relations
LifeSci Advisors, LLC
Sandya von der Weid
E: [e-mail]
T: [phone]

PDF: http://ml.globenewswire.com/Resource/Download/23ed1925-d4e3-4e19-9b34- ...